Literature DB >> 24964004

Vascular dysfunction in children conceived by assisted reproductive technologies: underlying mechanisms and future implications.

Stefano F Rimoldi1, Claudio Sartori2, Emrush Rexhaj1, David Cerny1, Robert Von Arx1, Rodrigo Soria1, Marc Germond3, Yves Allemann1, Urs Scherrer4.   

Abstract

Epidemiological studies in humans have demonstrated a relationship between pathological events during fetal development and increased cardiovascular risk later in life and have led to the so called "Fetal programming of cardiovascular disease hypothesis". The recent observation of generalised vascular dysfunction in young apparently healthy children conceived by assisted reproductive technologies (ART) provides a novel and potentially very important example of this hypothesis. This review summarises recent data in ART children demonstrating premature subclinical atherosclerosis in the systemic circulation and pulmonary vascular dysfunction predisposing to exaggerated hypoxia-induced pulmonary hypertension. These problems appear to be related to the ART procedure per se. Studies in ART mice demonstrating premature vascular aging and arterial hypertension further demonstrate the potential of ART to increase cardiovascular risk and have allowed to unravel epigenetic alterations of the eNOS gene as an underpinning mechanism. The roughly 25% shortening of the life span in ART mice challenged with a western style high-fat-diet demonstrates the potential importance of these alterations for the long-term outcome. Given the young age of the ART population, data on cardiovascular endpoints will not be available before 20 to 30 years from now. However, already now cohort studies of the ART population are needed to early detect cardiovascular alterations with the aim to prevent or at least optimally treat cardiovascular complications. Finally, a debate needs to be engaged on the future of ART and the consequences of its exponential growth for public health.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24964004     DOI: 10.4414/smw.2014.13973

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  7 in total

1.  Agonist depot versus OCP programming of frozen embryo transfer: a retrospective analysis of freeze-all cycles.

Authors:  Kemal Ozgur; Murat Berkkanoglu; Hasan Bulut; Peter Humaidan; Kevin Coetzee
Journal:  J Assist Reprod Genet       Date:  2015-12-23       Impact factor: 3.412

Review 2.  Can assisted reproductive technologies cause adult-onset disease? Evidence from human and mouse.

Authors:  Lisa A Vrooman; Marisa S Bartolomei
Journal:  Reprod Toxicol       Date:  2016-07-26       Impact factor: 3.143

3.  Pulmonary arterial pressure in at-term in vitro fertilization neonates: A cross-sectional study.

Authors:  Mohammad Reza Alipour; Zohreh Pezeshkpour; Seyedeh Mahdieh Namayandeh; Mohammadtaghi Sarebanhassanabadi
Journal:  Turk J Obstet Gynecol       Date:  2020-07-29

Review 4.  Vascular biology of ageing-Implications in hypertension.

Authors:  Adam Harvey; Augusto C Montezano; Rhian M Touyz
Journal:  J Mol Cell Cardiol       Date:  2015-04-17       Impact factor: 5.000

Review 5.  The periconceptional environment and cardiovascular disease: does in vitro embryo culture and transfer influence cardiovascular development and health?

Authors:  Monalisa Padhee; Song Zhang; Shervi Lie; Kimberley C Wang; Kimberley J Botting; I Caroline McMillen; Severence M MacLaughlin; Janna L Morrison
Journal:  Nutrients       Date:  2015-02-18       Impact factor: 5.717

6.  Increased blood pressure and impaired endothelial function after accelerated growth in IVF/ICSI children.

Authors:  H Zandstra; A P A van Montfoort; J C M Dumoulin; L J I Zimmermann; R N M Touwslager
Journal:  Hum Reprod Open       Date:  2020-01-07

Review 7.  Gonadotropin-releasing hormone agonist for ovulation trigger - OHSS prevention and use of modified luteal phase support for fresh embryo transfer.

Authors:  Juan Carlos Castillo; Thor Haahr; María Martínez-Moya; Peter Humaidan
Journal:  Ups J Med Sci       Date:  2020-05-04       Impact factor: 2.384

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.